×
S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54
How to Profit In The Bear Market
The Most Upgraded Stocks To Buy Before The 2nd Half Starts
What Makes QuantumScape (QS) An Interesting Stock Pick?
Should You Consider Polestar Stock After Its IPO?
Johnson's move to rewrite Brexit rules clears 1st hurdle
Is It Time To Pull The Trigger On Smith & Wesson Brands? 
Yacht of wealthiest Russian oligarch docked in haven Dubai
S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54
How to Profit In The Bear Market
The Most Upgraded Stocks To Buy Before The 2nd Half Starts
What Makes QuantumScape (QS) An Interesting Stock Pick?
Should You Consider Polestar Stock After Its IPO?
Johnson's move to rewrite Brexit rules clears 1st hurdle
Is It Time To Pull The Trigger On Smith & Wesson Brands? 
Yacht of wealthiest Russian oligarch docked in haven Dubai
S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54
How to Profit In The Bear Market
The Most Upgraded Stocks To Buy Before The 2nd Half Starts
What Makes QuantumScape (QS) An Interesting Stock Pick?
Should You Consider Polestar Stock After Its IPO?
Johnson's move to rewrite Brexit rules clears 1st hurdle
Is It Time To Pull The Trigger On Smith & Wesson Brands? 
Yacht of wealthiest Russian oligarch docked in haven Dubai
S&P 500   3,821.55
DOW   30,946.99
QQQ   283.54
How to Profit In The Bear Market
The Most Upgraded Stocks To Buy Before The 2nd Half Starts
What Makes QuantumScape (QS) An Interesting Stock Pick?
Should You Consider Polestar Stock After Its IPO?
Johnson's move to rewrite Brexit rules clears 1st hurdle
Is It Time To Pull The Trigger On Smith & Wesson Brands? 
Yacht of wealthiest Russian oligarch docked in haven Dubai

Dawson James Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Dawson James. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Dawson James.

All countries
MarketRank evaluates a company based on community opinion, dividend strength, institutional and insider ownership, earnings and valuation, and analysts forecasts.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
Export to Excel
CompanyDateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
CRKN
Crown ElectroKinetics
5/16/2022Target Lowered byDawson James$4.50 -> $1.50Low
KTRA
Kintara Therapeutics
5/16/2022Downgraded byDawson JamesAnalyst J. KolbertBuy -> NeutralLow
BYRN
Byrna Technologies
4/26/2022Initiated byDawson JamesBuy $12.00High
CRKN
Crown ElectroKinetics
3/18/2022Target Lowered byDawson JamesBuy$8.50 -> $4.25Medium
FUV
Arcimoto
3/15/2022Initiated byDawson JamesNeutralMedium
LCTX
Lineage Cell Therapeutics
3/11/2022Reiterated byDawson JamesAnalyst Jason KolbertBuy $6.00N/A
SMSI
Smith Micro Software
3/11/2022Target Lowered byDawson JamesBuy$11.40 -> $8.30High
PFIE
Profire Energy
3/9/2022Target Raised byDawson James$1.65 -> $2.00Low
KNWN
Know Labs
2/8/2022Initiated byDawson JamesBuy $7.00High
CHEK
Check-Cap
2/7/2022Upgraded byDawson JamesNeutral -> BuyHigh
SFET
Safe-T Group
1/31/2022Initiated byDawson JamesBuy $6.00High
BJDX
Bluejay Diagnostics
1/12/2022Initiated byDawson JamesAnalyst J. KolbertBuy $10.00High
SRAX
SRAX
1/10/2022Target Raised byDawson James$11.50 -> $13.00Medium
XXII
22nd Century Group
1/6/2022Target Raised byDawson JamesAnalyst James McIlreeBuy -> Buy$7.00 -> $8.50N/A
BCLI
Brainstorm Cell Therapeutics
12/22/2021Reiterated byDawson JamesAnalyst J. KolbertNeutralMedium
VUZI
Vuzix
12/21/2021Initiated byDawson JamesBuy $15.00Medium
GNUS
Genius Brands International
12/15/2021Initiated byDawson JamesBuy $5.00High
ADMP
Adamis Pharmaceuticals
12/3/2021Reiterated byDawson JamesAnalyst J. KolbertNeutralHigh
PRPH
ProPhase Labs
10/13/2021Downgraded byDawson JamesAnalyst J. KolbertBuy -> NeutralMedium
BTTR
Better Choice
8/31/2021Initiated byDawson JamesBuyHigh
SRAX
SRAX
8/18/2021Target Raised byDawson JamesOutperform -> Buy$5.00 -> $5.75Medium
PFIE
Profire Energy
8/5/2021Initiated byDawson JamesAnalyst James McIlreeBuy $1.65High
CRKN
Crown ElectroKinetics
8/5/2021Initiated byDawson JamesBuy $8.50High
SMSI
Smith Micro Software
8/5/2021Initiated byDawson JamesBuy $11.10High
AVXL
Anavex Life Sciences
6/21/2021Target Raised byDawson JamesBuy$19.00 -> $35.00Low
ARTH
Arch Therapeutics
5/5/2021Initiated byDawson JamesAnalyst J. KolbertBuyLow
BCDA
BioCardia
4/22/2021Reiterated byDawson JamesAnalyst J. KolbertBuy -> NeutralMedium
SRAX
SRAX
4/19/2021Initiated byDawson JamesBuy $5.00High
BCDA
BioCardia
4/16/2021Downgraded byDawson JamesAnalyst J. KolbertBuy -> NeutralHigh
CHEK
Check-Cap
3/17/2021Reiterated byDawson JamesAnalyst J. KolbertBuy -> Neutral $2.00Low
CTXR
Citius Pharmaceuticals
2/25/2021Reiterated byDawson JamesAnalyst J. KolbertBuy $6.00Low
FBIO
Fortress Biotech
2/17/2021Target Raised byDawson JamesBuy$16.00 -> $21.00Low
PRPH
ProPhase Labs
1/20/2021Initiated byDawson JamesBuy $25.00High
ISR
Isoray
10/20/2020Downgraded byDawson JamesAnalyst J. KolbertBuy -> NeutralN/A
ATHX
Athersys
10/12/2020Reiterated byDawson JamesBuyLow
LCTX
Lineage Cell Therapeutics
10/12/2020Reiterated byDawson JamesBuy $6.00N/A
PSTI
Pluristem Therapeutics
10/9/2020Reiterated byDawson JamesBuy $12.00Low
CTXR
Citius Pharmaceuticals
9/17/2020Reiterated byDawson JamesAnalyst J. KolbertBuyLow
ONCS
OncoSec Medical
8/27/2020Reiterated byDawson JamesAnalyst J. KolbertBuyMedium
ADMP
Adamis Pharmaceuticals
8/24/2020Downgraded byDawson JamesAnalyst J. KolbertBuy -> NeutralMedium
SNGX
Soligenix
7/28/2020Downgraded byDawson JamesAnalyst J. KolbertBuy -> Neutral$3.00 -> $2.00High
ONCS
OncoSec Medical
7/27/2020Initiated byDawson JamesBuy $10.00Low
CLSN
Celsion
7/13/2020Downgraded byDawson JamesAnalyst Jason KolbertBuy -> NeutralMedium
DARE
Daré Bioscience
7/12/2020Reiterated byDawson JamesBuy $3.00High
CLSN
Celsion
6/24/2020Reiterated byDawson JamesBuy $60.00Low
ADMP
Adamis Pharmaceuticals
6/15/2020Upgraded byDawson JamesAnalyst Jason KolbertBuy $1.00Medium
AVXL
Anavex Life Sciences
6/8/2020Reiterated byDawson JamesBuy $16.00Medium
SRNE
Sorrento Therapeutics
5/26/2020Initiated byDawson JamesBuy -> Buy $24.00Low
CLBS
Caladrius Biosciences
5/18/2020Downgraded byDawson JamesAnalyst J. KolbertBuy -> NeutralHigh
ATHX
Athersys
5/6/2020Reiterated byDawson JamesBuy $12.00Low
PSTI
Pluristem Therapeutics
4/15/2020Reiterated byDawson JamesAnalyst Jason KolbertBuyHigh
CTSO
Cytosorbents
3/9/2020Reiterated byDawson JamesBuy$15.00 -> $17.00High
ADMP
Adamis Pharmaceuticals
2/27/2020Downgraded byDawson JamesAnalyst J. KolbertBuy -> NeutralHigh
DYAI
Dyadic International
2/26/2020Reiterated byDawson JamesAnalyst Jason KolbertBuyHigh
IMAC
IMAC
1/14/2020Reiterated byDawson JamesAnalyst J. KolbertBuy -> NeutralLow
MESO
Mesoblast
12/19/2019Initiated byDawson JamesAnalyst Jason KolbertBuy $14.00Low
PSTI
Pluristem Therapeutics
12/16/2019Initiated byDawson JamesBuy $12.00High
CHEK
Check-Cap
12/5/2019Initiated byDawson JamesBuy $4.00Low
DYAI
Dyadic International
10/16/2019Initiated byDawson JamesBuy $14.00Low
EMMA
Emmaus Life Sciences
9/24/2019Downgraded byDawson JamesBuy -> NeutralHigh
BCDA
BioCardia
9/17/2019Initiated byDawson JamesAnalyst Jason KolbertBuy $24.00Low
BCDA
BioCardia
9/17/2019Reiterated byDawson JamesAnalyst J. KolbertBuyMedium
CTXR
Citius Pharmaceuticals
9/6/2019Initiated byDawson JamesAnalyst Jason KolbertBuy $7.00N/A
FBIO
Fortress Biotech
8/26/2019Initiated byDawson JamesBuy $19.00High
ATHX
Athersys
8/26/2019Initiated byDawson JamesBuy $11.00High
ADMA
ADMA Biologics
8/12/2019Downgraded byDawson JamesAnalyst J. KolbertBuy -> Neutral $4.00High
AVXL
Anavex Life Sciences
7/24/2019Initiated byDawson JamesAnalyst J. KolbertBuy $16.00Low
KTRA
Kintara Therapeutics
7/11/2019Reiterated byDawson JamesAnalyst J. KolbertBuyHigh
ISR
Isoray
7/1/2019Initiated byDawson JamesAnalyst Jason KolbertBuyN/A
ADMP
Adamis Pharmaceuticals
7/2/2019Initiated byDawson JamesAnalyst Jason KolbertBuyMedium
ADIL
Adial Pharmaceuticals
4/12/2019Reiterated byDawson JamesAnalyst R. WassermanBuyMedium
CLBS
Caladrius Biosciences
2/27/2019Reiterated byDawson JamesAnalyst J. KolbertBuyMedium
BTX
Brooklyn ImmunoTherapeutics
2/7/2019Initiated byDawson JamesBuyN/A
NAOV
NanoVibronix
1/9/2019Initiated byDawson JamesAnalyst R. WassermanBuyLow
INTT
inTEST
12/28/2018Reiterated byDawson JamesAnalyst B. SineBuyHigh
ORGS
Orgenesis
12/20/2018Reiterated byDawson JamesAnalyst C. WertherBuyHigh
SSNT
SilverSun Technologies
12/19/2018Reiterated byDawson JamesAnalyst B. SineBuyHigh
BCLI
Brainstorm Cell Therapeutics
12/18/2018Reiterated byDawson JamesAnalyst J. KolbertBuyHigh
ORGS
Orgenesis
12/20/2018Initiated byDawson JamesBuy -> BuyMedium
GVP
GSE Systems
12/18/2018Reiterated byDawson JamesAnalyst B. SineBuyHigh
FTNW
FTE Networks
12/11/2018Reiterated byDawson JamesAnalyst B. SineBuyN/A
WYY
WidePoint
12/3/2018Reiterated byDawson JamesAnalyst B. SineBuyHigh
WTT
Wireless Telecom Group
12/3/2018Reiterated byDawson JamesAnalyst B. SineBuyLow
ONCS
OncoSec Medical
11/7/2018Downgraded byDawson JamesAnalyst R. WassermanBuy -> NeutralLow
CIDM
Cinedigm
10/22/2018Initiated byDawson JamesAnalyst B. SineBuyLow
FRX
Fennec Pharmaceuticals
10/10/2018Reiterated byDawson JamesAnalyst C. WertherBuyN/A
ADIL
Adial Pharmaceuticals
10/11/2018Initiated byDawson JamesAnalyst C. WertherBuyHigh
FENC
Fennec Pharmaceuticals
10/11/2018Initiated byDawson JamesAnalyst C. WertherBuyHigh
BIOC
Biocept
10/3/2018Reiterated byDawson JamesAnalyst R. WassermanBuyHigh
ADIL
Adial Pharmaceuticals
10/1/2018Reiterated byDawson JamesAnalyst C. WertherBuyLow
LUNA
Luna Innovations
10/2/2018Initiated byDawson JamesAnalyst B. SineBuyLow
SSKN
STRATA Skin Sciences
9/4/2018Initiated byDawson JamesAnalyst R. WassermanBuyHigh
ONCS
OncoSec Medical
7/16/2018Reiterated byDawson JamesAnalyst R. WassermanBuyLow
VERU
Veru
6/25/2018Reiterated byDawson JamesAnalyst R. WassermanBuyMedium
IMV
IMV
6/19/2018Reiterated byDawson JamesAnalyst C. WertherBuyN/A
IMV
IMV
6/19/2018Reiterated byDawson JamesAnalyst C. WertherBuyMedium
LIVX
LiveXLive Media
6/4/2018Reiterated byDawson JamesAnalyst B. SineBuyMedium
ALT
Altimmune
5/29/2018Reiterated byDawson JamesAnalyst R. WassermanBuyHigh
VYNT
Vyant Bio
4/6/2018Downgraded byDawson JamesAnalyst R. WassermanBuy -> NeutralHigh
ACST
Acasti Pharma
1/29/2018Reiterated byDawson JamesAnalyst R. WassermanBuyLow
CVM
CEL-SCI
10/16/2017Reiterated byDawson JamesAnalyst R. WassermanNeutralN/A
PULM
Pulmatrix
9/27/2017Reiterated byDawson JamesAnalyst R. WassermanBuyMedium
PAVM
PAVmed
9/5/2017Reiterated byDawson JamesAnalyst R. WassermanBuy $10.10High
TNXP
Tonix Pharmaceuticals
8/23/2017Reiterated byDawson JamesAnalyst R. WassermanBuy $2,880.00Medium
KTRA
Kintara Therapeutics
8/8/2017Reiterated byDawson JamesAnalyst R. WassermanBuyHigh
EPIX
ESSA Pharma
8/3/2017Reiterated byDawson JamesAnalyst R. WassermanBuyHigh
ONTX
Onconova Therapeutics
7/25/2017Reiterated byDawson JamesAnalyst R. WassermanBuyHigh
ONCS
OncoSec Medical
7/6/2017Reiterated byDawson JamesAnalyst R. WassermanBuy $50.00High
VYNT
Vyant Bio
6/27/2017Initiated byDawson JamesAnalyst R. WassermanBuyHigh
OPGN
OpGen
6/19/2017Reiterated byDawson JamesAnalyst R. WassermanBuyLow
CVM
CEL-SCI
3/11/2016Reiterated byDawson JamesAnalyst R. WassermanBuyN/A
NURO
NeuroMetrix
2/29/2016Reiterated byDawson JamesAnalyst R. WassermanBuyN/A
ENZ
Enzo Biochem
2/9/2016Reiterated byDawson JamesAnalyst R. WassermanBuyN/A
SLNO
Soleno Therapeutics
5/6/2015Initiated byDawson JamesBuy $63.50N/A
CVM
CEL-SCI
3/2/2015Initiated byDawson JamesBuy $3.00N/A
PULM
Pulmatrix
6/25/2014Initiated byDawson JamesBuy $2,400.00N/A
AXGN
AxoGen
5/14/2014Initiated byDawson JamesBuy $5.00N/A
NEO
NeoGenomics
5/14/2014Initiated byDawson JamesBuy $6.00N/A
ABIO
ARCA biopharma
10/9/2013Initiated byDawson JamesBuy $3.75N/A
AGEN
Agenus
3/12/2013Reiterated byDawson JamesBuyN/A
MD
MEDNAX
3/12/2013Downgraded byDawson JamesBuy -> Neutral $80.00N/A
ARWR
Arrowhead Pharmaceuticals
2/26/2013Initiated byDawson JamesBuy $4.00N/A
ATOS
Atossa Therapeutics
12/20/2012Initiated byDawson JamesOutperform $120.00N/A
BMY
Bristol-Myers Squibb
12/12/2012Reiterated byDawson JamesMarket Outperform $51.00N/A
AMGN
Amgen
12/7/2012Initiated byDawson JamesOutperform $91.00N/A
GEO
The GEO Group
12/4/2012Downgraded byDawson JamesMarket PerformN/A
NAVB
Navidea Biopharmaceuticals
11/27/2012Initiated byDawson JamesOutperformN/A
CLSN
Celsion
11/27/2012Initiated byDawson JamesOutperform $1,890.00N/A
SPPI
Spectrum Pharmaceuticals
11/27/2012Initiated byDawson JamesOutperform $15.00N/A
SRPT
Sarepta Therapeutics
11/27/2012Initiated byDawson JamesOutperformN/A
RMTI
Rockwell Medical
11/27/2012Initiated byDawson JamesOutperform $132.00N/A
AGEN
Agenus
11/27/2012Initiated byDawson JamesOutperformN/A
SLS
SELLAS Life Sciences Group
11/27/2012Initiated byDawson JamesOutperform $150.00N/A
CYTK
Cytokinetics
11/27/2012Downgraded byDawson JamesOutperformN/A
GALT
Galectin Therapeutics
7/6/2012Target Lowered byDawson JamesBuy $3.00N/A
TNXP
Tonix Pharmaceuticals
4/26/2012Initiated byDawson JamesBuy $1,280.00N/A
NFLX
Netflix
10/28/2011Target Lowered byDawson JamesSell$16.50 -> $7.14N/A

MarketBeat Community Rating for Dawson James

Community Ranking:  2.8 out of 5 (
2.8 of 5 stars)
Outperform Votes:  17,755 (Vote Outperform)
Underperform Votes:  14,143 (Vote Underperform)
Total Votes:  31,898
MarketBeat's community ratings are surveys of what our community members think about Dawson James and other research firms. Vote "Outperform" if you believe Dawson James's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Dawson James's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.
See Also:

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.